Healthcare ❯ Pharmaceuticals ❯ Clinical Trials

Rare Diseases

Osteogenesis Imperfecta Netherton Syndrome

Law Firms Seek Ultragenyx Investors to Lead Securities Class Actions After OI Trial Miss

The early filings start a contest to pick a lead plaintiff who will choose counsel and shape the case.

Mereo BioPharma Investors Face April 6 Deadline in Lawsuits Over Failed Setrusumab Trials

Quoin Pharmaceuticals Shares Jump on $104.5 Million Private Placement With $16.8 Million Upfront